Course Catalog
Browse our full catalog of continuing education courses and events
Browse Courses & Events
Community Oncology Connections™: Immunotherapy Across the SCLC Continuum: Optimizing Treatment Pathways From Limited-Stage Through Relapsed Disease | New Jersey Regional Program
Neel Belani, MD; Anne Chiang, MD, PhD
Project ECHO®: Advancing Personalized Care Across the HR+/HER2– Breast Cancer Continuum
Webinar Series
Community Oncology Connections™: Bridging Academic and Community Connections to Advance Precision and Targeted Care in NF1 Plexiform Neurofibromas | Tennessee Oncology Practice Society
Amy E. Armstrong, MD; Tarun Wasil, MBBS
Community Oncology Connections: Navigating PD-L1–Driven Decisions and ADC Integration in Frontline mTNBC
Neil M. Iyengar, MD; Sara M. Tolaney, MD, MPH
Beyond the Basics in CIDP — Confronting Misdiagnosis and Rethinking Treatment Strategy
Thomas H. Brannagan III, MD
Medical Crossfire®: Where CAR T and Bispecific Antibodies Fit in Lymphoid Malignancies Today… and Tomorrow
Krina K. Patel, MD, MSc; Juan Pablo Alderuccio, MD; Christopher R. Flowers, MD, MS, FASCO; Matthew L...
Navigating the Evolving Landscape of Acute Lymphoblastic Leukemia
Hagop M. Kantarjian, MD; Elias Jabbour, MD; Aaron C. Logan, MD, PhD, MPhil
Reel Time Patient Counseling™: Improving Quality of Life for Patients With Acute Pain
Javier Morales, MD; Charles E. Argoff, MD
Medical Crossfire®: ADCs and Bispecifics in Lung Cancer—Hype, Hope, or a New Standard of Care?
Sandip Patel, MD, FASCO; Enriqueta Felip, MD, PhD; Marina Chiara Garassino, MD; Eric K. Singhi, MD
What, When, In What Order? Navigating the Ever-Expanding Treatment Landscape for Generalized Myasthenia Gravis
Ali A. Habib, MD
Multidisciplinary Approaches to Diagnosis and Management of Muscular Dystrophy
Katherine Mathews, MD
What Is Coming Down the Pipeline for Generalized Myasthenia Gravis (gMG)?
James F. Howard Jr, MD, FAAN
Myasthenia Mimics — How to Differentiate Between Similar Neuromuscular Disorders
Ali A. Habib, MD
Community Oncology Connections™: Advancing Precision Testing and HER2-Targeted Care for Gastroesophageal Adenocarcinoma | Rhode Island Oncology Society
Shiven Patel, MD, MBA, FACP; Sunnie S. Kim, MD
𝘒𝘙𝘈𝘚 in Focus: Navigating the Mutation-Driven Oncology Landscape – Nursing
David S. Hong MD; Kathryn C. Arbour, MD; Shubham Pant, MD, MBBS; Alison Schram, MD
From Lived Experience to Precision Care: Patient, Provider, and Caregiver Insights in Cutaneous Lupus Erythematosus
Alfred Kim, MD; Victoria Werth, MD
Cases & Conversations: Real-World Insights on the Diagnosis and Management of Cold Agglutinin Disease
Catherine M. Broome, MD; Wilma Barcellini, MD, PhD; Sigbjørn Berentsen, MD, PhD; Marc Michel, MD, MS...
Community Oncology Connections: Navigating PD-L1–Driven Decisions and ADC Integration in Frontline mTNBC | Wyoming State Oncology Society & Montana State Oncology Society
Sarah M. Tolaney, MD, MPH; Yelda Nouri, MD
Community Oncology Connections™: Advancing Precision Testing and HER2-Targeted Care for Gastroesophageal Adenocarcinoma – Indiana Oncology Society
Geoffrey Ku, MD; Girish Kunapareddy, MD
Community Oncology Connections™: Bridging Academic and Community Connections to Advance Precision and Targeted Care in NF1 Plexiform Neurofibromas | North Carolina Oncology Association
Daniela A. Bota, MD, PhD; Maya Hrachova, DO
Community Practice Connections™: Bridging Academic and Community Connections to Advance Precision and Targeted Care in NF1 Plexiform Neurofibromas
Amy E. Armstrong, MD; Daniela A. Bota, MD, PhD
Community Oncology Connections™: How Can We Optimize the Use of Oral SERDs in the Community Oncology Setting? Best Practices for HR+/HER2– Breast Cancer | Wisconsin Association of Hematology and Oncology
Virginia Kaklamani, MD, DSc; Girish Kunapareddy, MD
Cases and Conversations: Personalizing ARPI Therapy Across the Prostate Cancer Continuum
December 1, 2026
Community Oncology Connections™: How Can We Optimize the Use of Oral SERDs in the Community Oncology Setting? Best Practices for HR+/HER2– Breast Cancer | Empire State Hematology & Oncology Society
Wassim Mchayleh, MD, MBA, FACP; Yelda Nouri, MD
Community Oncology Connections: Navigating PD-L1–Driven Decisions and ADC Integration in Frontline mTNBC | West Virginia
Neil M. Iyengar, MD; Swati Vishwanathan, MD
Community Oncology Connections™: Bridging Academic and Community Expertise in Evidence-Based Care for Desmoid Tumors | South Carolina Oncology Society
Tony Philip, MD, FACP, FASCO; Mrinal M. Gounder, MD
Live Tumor Board: Decoding Neuroendocrine Neoplasms – Practical Advances in Diagnostics, Emerging Treatments, and Real-World Management
October 18, 2026
Show Me Your Care Plan!™ Navigating ADC Therapies: Oncology Nursing Strategies for Optimal Patient Management
Edward B. Garon, MD, MS; Emely Alfaro, DNP, RN, CNS, OCN; Marianne Davies, NP, DNP, MSN, APRN, BSN; ...
Patient, Provider, Caregiver Connection™: Individualized Care in Pediatric Atopic Dermatitis
Elizabeth (Lisa) A. Swanson, MD; Linda Stein Gold, MD
Community Oncology Connections™: Advancing Precision Testing and HER2-Targeted Care for Gastroesophageal Adenocarcinoma – Missouri Oncology Society
Geoffrey Ku, MD; Shiven B. Patel, MD, MBA, FACP
Community Oncology Connections™: Advancing Precision Testing and HER2-Targeted Care for Gastroesophageal Adenocarcinoma – Louisiana Oncology Society
Geoffrey Ku, MD; Philip A. Haddad, MD, MPH, MHA, MS(HCI)
Medical Crossfire®: Personalizing the Management of Multiple Sclerosis: Optimizing the Selection of Disease Modifying Therapies
Benjamin Greenberg, MD; Jiwon Oh, MD; Amy Perrin Ross, APN, MSN, CNRN, MSCN
Clinical Crossroads™: The Importance of Timely Identification and Management of Risk Factors for Seizure Clusters
Joseph I. Sirven, MD; Danielle Becker, MD, MS
𝘔𝘌𝘛 Alterations in NSCLC: Applying Diagnostic Advances and Targeted Therapies in a New Era of Treatment
Jonathan Goldman, MD; Sanja Dacic, MD, PhD; Deborah Doroshow, MD, PhD; Anne S. Tsao, MD, MBA
Community Oncology Connections: Navigating PD-L1–Driven Decisions and ADC Integration in Frontline mTNBC | Minnesota
Neil M. Iyengar, MD; Girish Kunapareddy, MD
PER Postgame: Maximizing Durability Across Retinal Disease — What 3 Years of Evidence Means for Your Practice
Judy E. Kim, MD, FARVO, FASRS
Show Me the Data™: Turning Molecular Drivers Into Precision Care for CNS Tumors
November 12, 2026
BURST CME™ Activity 4: Case-Based Discussions in HR+/HER2– MBC: Incorporating the Latest Data Into Practice
Erica L. Mayer, MD, MPH; Jason Aboudi Mouabbi, MD; Erika P. Hamilton, MD
Project ECHO®: Managing Toxicities and Expectations With Novel Treatment Strategies in mTNBC: A Team-Based Approach
Tiffany A. Traina, MD, FASCO; Nour Abuhadra, MD; Ya Haddy Sallah, MD, MPH; Odessa M. Williams, AGPCN...
Community Oncology Connections™: Monotherapies vs Combinations – Navigating Oral SERDs and Targeted Combination Strategies in HR+/HER2- Metastatic Breast Cancer | Nevada Oncology Society
Sara A. Hurvitz, MD, FACP; Ajit K. Bisen, MD, MBA
Community Oncology Connections™: Monotherapies vs Combinations – Navigating Oral SERDs and Targeted Combination Strategies in HR+/HER2- Metastatic Breast Cancer | The Arizona Clinical Oncology Society
Sara A. Hurvitz, MD, FACP; Milana Dolezal, MD, MSci